Vaccination programs for pregnant women in Europe, 2021.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 28 03 2021
revised: 14 08 2021
accepted: 19 08 2021
pubmed: 1 9 2021
medline: 25 2 2023
entrez: 31 8 2021
Statut: ppublish

Résumé

Vaccination during pregnancy is increasingly adopted worldwide in order to protect the mother and her offspring. We studied the current vaccination programs specifically for pregnant women in 42 European countries. Vaccination programs for pregnant women are in place in 37 countries, as follows: influenza (36 countries), pertussis (28), hepatitis B (12), tetanus (10), pneumococcal disease (10), meningococcal disease (10), rabies (8), tick-borne encephalitis (6), hepatitis A (5), poliomyelitis (4), diphtheria (3), Haemophilus influenzae (2), and human papilloma virus (1). Recommendations for vaccination against influenza and pertussis concern almost exclusively pregnant women regardless of high-risk conditions, however differences between vaccination recommendations are noted in terms of timing. Vaccinations against hepatitis B, hepatitis A, pneumococcal disease, meningococcal disease, poliomyelitis, H. influenzae, rabies, and tick-born encephalitis mainly concern pregnant women at high-risk for exposure or serious illness and post-exposure vaccinations. Overall, five European countries have no vaccination recommendations specifically for pregnant women. In conclusion, there are significant differences in vaccination programs for pregnant women in Europe. Vaccination programs for pregnant women should expand in order to protect maternal and infant health. A consensus-based vaccination program is needed.

Identifiants

pubmed: 34462162
pii: S0264-410X(21)01122-1
doi: 10.1016/j.vaccine.2021.08.074
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6137-6143

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Helena C Maltezou (HC)

Directorate of Research, Studies and Documentation, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.

Evgnosia Effraimidou (E)

Pediatric Department, Democritus University of Thrace, Alexandroupolis, Greece.

Dimitrios C Cassimos (DC)

Pediatric Department, Democritus University of Thrace, Alexandroupolis, Greece.

Snezana Medic (S)

Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia; Center for Disease Control and Prevention, Institute of Public Health of Vojvodina, Novi Sad, Serbia.

Maria Topalidou (M)

Pediatric Clinic, Komotini General Hospital, Komotini, Greece.

Theocharis Konstantinidis (T)

Blood Transfussion Center, University General Hospital of Alexandroupolis, Alexandroupolis, Greece.

Maria Theodoridou (M)

First Department of Pediatrics, University of Athens, Athens, Greece.

Alexandros Rodolakis (A)

First Department of Obstetrics and Gynecology, University of Athens, Alexandra General Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH